No Link Seen Between GLP-1 Receptor Agonist Use and Thyroid Cancer

WEDNESDAY, Jan. 22, 2025-- Glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is not associated with an increased risk for thyroid cancer over the short term, according to a study published online Jan. 16 in Thyroid.Sarah M. Baxter, from...